Results for tag: "Nalbuphine"

Nalbuphine is an analgesic drug used to treat moderate to severe pain. It is a semi-synthetic opioid agonist-antagonist, meaning it has both opioid agonist and antagonist properties. It is a Schedule IV controlled substance in the United States, meaning it has a low potential for abuse and dependence. Nalbuphine is available in both oral and injectable forms, and is commonly used in hospitals and other medical settings. Nalbuphine is used to treat a variety of conditions, including postoperative pain, chronic pain, and cancer pain. It is also used to treat opioid-induced respiratory depression, a condition in which the patient's breathing is slowed or stopped due to the effects of opioids. Nalbuphine is generally considered to be a safe and effective analgesic, with few side effects. In the Nalbuphine market, some of the major players include Endo Pharmaceuticals, Mylan Pharmaceuticals, and Teva Pharmaceuticals. Other companies in the market include Actavis, Hospira, and Sun Pharmaceuticals. Show Less Read more